MedPath

European Organisation For Research & Treatment Of Cancer

🇬🇧United Kingdom
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.eortc.be

E7070 in Treating Patients With Stage IV Melanoma

Phase 2
Completed
Conditions
Melanoma (Skin)
First Posted Date
2004-02-16
Last Posted Date
2012-07-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
28
Registration Number
NCT00014625
Locations
🇧🇪

Institut Jules Bordet, Brussels, Belgium

🇦🇹

Kaiser Franz Josef Hospital, Vienna, Austria

🇵🇹

Instituto Portugues de Oncologia de Francisco Gentil, Lisbon, Portugal

and more 9 locations

Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

Phase 2
Completed
Conditions
Leukemia
First Posted Date
2004-02-16
Last Posted Date
2012-07-16
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
106
Registration Number
NCT00006122
Locations
🇫🇷

Hotel Dieu de Paris, Paris, France

🇧🇪

A.Z. St. Jan, Brugge, Belgium

🇦🇹

Innsbruck Universitaetsklinik, Innsbruck, Austria

and more 15 locations

Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
First Posted Date
2004-02-16
Last Posted Date
2012-07-02
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
70
Registration Number
NCT00003062
Locations
🇵🇱

Medical University of Gdansk, Gdansk, Poland

🇳🇱

Vrije Universiteit Medisch Centrum, Amsterdam, Netherlands

🇮🇹

Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

and more 2 locations

Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma

Phase 3
Completed
Conditions
Brain and Central Nervous System Tumors
First Posted Date
2004-02-16
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
25
Registration Number
NCT00003916
Locations
🇩🇪

Medizinische Klinik I, Dresden, Germany

🇪🇸

Institut Catala d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain

🇨🇭

Universitaetsspital, Zurich, Switzerland

and more 5 locations

Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome

Phase 2
Completed
Conditions
Leukemia
Myelodysplastic Syndromes
First Posted Date
2004-02-11
Last Posted Date
2012-07-16
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
31
Registration Number
NCT00077116
Locations
🇨🇭

Universitaetsspital-Basel, Basel, Switzerland

🇧🇪

AZ Sint-Jan, Brugge, Belgium

🇧🇪

H. Hartziekenhuis - Roeselaere., Roeselare, Belgium

and more 6 locations

Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer

Phase 1
Completed
Conditions
Breast Cancer
First Posted Date
2004-02-03
Last Posted Date
2012-07-18
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
15
Registration Number
NCT00008034
Locations
🇨🇭

Hopital Cantonal Universitaire de Geneva, Geneva, Switzerland

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

Phase 3
Completed
Conditions
Head and Neck Cancer
First Posted Date
2004-01-29
Last Posted Date
2018-07-09
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
359
Registration Number
NCT00003888
Locations

Institute of Oncology and Radiology of Serbia, Belgrade, Former Yugoslavia

🇫🇷

CHR de Besancon - Hopital Jean Minjoz, Besancon, France

🇫🇷

Centre Hospital Regional Universitaire de Limoges, Limoges, France

and more 41 locations

Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Phase 3
Completed
Conditions
Colorectal Cancer
First Posted Date
2004-01-23
Last Posted Date
2012-07-02
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
554
Registration Number
NCT00003287
Locations
🇬🇷

University Hospital of Heraklion, Iraklion (Heraklion), Crete, Greece

🇫🇷

Centre Hospitalier de Montlucon, Montlucon, France

🇫🇷

Hopital Notre-Dame de Bon Secours, Metz, France

and more 33 locations

Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma

Phase 3
Completed
Conditions
Brain and Central Nervous System Tumors
First Posted Date
2004-01-22
Last Posted Date
2012-07-10
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
350
Registration Number
NCT00002840
Locations
🇫🇷

CHU de la Timone, Marseille, France

🇫🇷

CRLCC Nantes - Atlantique, Nantes-Saint Herblain, France

🇧🇪

Hopital Universitaire Erasme, Brussels, Belgium

and more 37 locations

Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Phase 3
Completed
Conditions
Brain and Central Nervous System Tumors
First Posted Date
2003-12-24
Last Posted Date
2012-09-24
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Target Recruit Count
575
Registration Number
NCT00006353
Locations
🇨🇦

Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada

🇨🇦

Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada

🇨🇦

Cross Cancer Institute, Edmonton, Alberta, Canada

and more 13 locations
© Copyright 2025. All Rights Reserved by MedPath